|
NUP98 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.57539999998424E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.562850E-04 |
| Normal-vs-Stage2 |
1.981390E-03 |
| Normal-vs-Stage3 |
1.60419999999384E-05 |
| Normal-vs-Stage4 |
3.887800000002E-05 |
| Stage1-vs-Stage2 |
4.293600E-01 |
| Stage1-vs-Stage3 |
7.861900E-02 |
| Stage1-vs-Stage4 |
9.430100E-02 |
| Stage2-vs-Stage3 |
6.750200E-01 |
| Stage2-vs-Stage4 |
6.940400E-01 |
| Stage3-vs-Stage4 |
9.976400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68615999999178E-05 |
| Normal-vs-AfricanAmerican |
1.557240E-01 |
| Normal-vs-Asian |
5.578800E-03 |
| Caucasian-vs-AfricanAmerican |
1.972830E-01 |
| Caucasian-vs-Asian |
7.502000E-01 |
| AfricanAmerican-vs-Asian |
4.068800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93600000000438E-05 |
| Normal-vs-Female |
2.35449999999027E-05 |
| Male-vs-Female |
4.931400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.555130E-03 |
| Normal-vs-Age(41-60Yrs) |
2.2149999999943E-05 |
| Normal-vs-Age(61-80Yrs) |
9.74859999947064E-07 |
| Normal-vs-Age(81-100Yrs) |
8.774500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.325450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.303800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.291800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.680220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.916200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.207800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.056570E-01 |
| Classical-VS-Follicular |
2.25859999999356E-05 |
| Classical-VS-Other |
1.051650E-01 |
| Classical-VS-Normal |
1.322840E-03 |
| Tall-VS-Follicular |
2.996800E-01 |
| Tall-VS-Other |
3.866000E-01 |
| Tall-VS-Normal |
4.820600E-04 |
| Follicular-VS-Other |
8.762600E-01 |
| Follicular-VS-Normal |
2.83270000012159E-07 |
| Other-VS-Normal |
1.413930E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.23650000003217E-06 |
| Normal-vs-N1 |
9.82670000000407E-05 |
| N0-vs-N1 |
6.960000E-01 |
|
|
